Form 4 for GTBP GT Biopharma, Inc.
Accepted 2021-10-07 00:00:00 ET · period of report 2020-11-16 · accession 0001654954-21-010887 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-10-07 | 2021-02-16 | GTBP | Wendel Bruce | Dir | A - Grant | $0.00 | +347.6K | 352.7K | +6,838% | $0 |
| DM | 2021-10-07 | 2020-11-16+ | GTBP | Wendel Bruce | Dir | P - Purchase | $5.17 | +5,083 | 4,642 | New | +$26.3K |
| D | 2021-10-07 | 2021-02-16 | GTBP | Wendel Bruce | Dir | A - Grant | $0.00 | +50.0K | 50.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-02-16 | A | A | 347,572 | $0.00 | 352,655 | D | — | — | (F1) Represents a grant of shares of restricted stock ("RSAs"). 1/3rd of the RSAs vest on November 11 2020, 2021 and 2022. |
| 2 | Common | Common Stock | 2020-11-16 | P | A | 3,268 | $3.14 | 3,268 | D | — | — | |
| 3 | Common | Common Stock | 2020-12-22 | P | A | 441 | $8.73 | 5,083 | D | — | — | |
| 4 | Common | Common Stock | 2020-12-22 | P | A | 1,374 | $8.87 | 4,642 | D | — | — | |
| 5 | Derivative | Option to purchase Common Stock | 2021-02-16 | A | A | 50,000 | $0.00 | 50,000 | D | $6.33 · — to 2031-02-15 | 50,000 Common Stock | (F2) 1/3rd of the shares vest on February 16, 2021, 2022, and 2023. |